Female sexual dysfunction in psoriasis: a systematic review and meta-analysis using the Female Sexual Function Index

Shah, Syed Fazal Hussein; Merchant, Serena Altaf; Shah, Syed Ameer

doi:10.1038/s41443-022-00650-9

Cited by 5 publications

(7 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Meeuwis and Türel Ermertcan et al obtained similar results to ours with decreased total FSFI in psoriatic women ( 29 , 31 ). In a recent meta-analysis of sexual dysfunctions in psoriatic women, it has been found that female patients have bigger odds of dysfunctions (OR 2.67, 95% CI) and lower scores in all the domains of FSFI, except for pain ( 35 ). In one study, Molina-Leyva et al used the Massachusetts General Hospital-Sexual Functioning Questionnaire (MGH-SFQ) which has similar domains compared to FSFI/IIEF and can be administered to both sexes.…”

Section: Discussionmentioning

confidence: 99%

“…Meeuwis and Türel Ermertcan et al obtained similar results to ours with decreased total FSFI in psoriatic women (29, 31). In a recent meta-analysis of sexual dysfunctions in psoriatic women, it has been found that female patients have bigger odds of dysfunctions (OR 2.67, 95% CI) and lower scores in all the domains of FSFI, except for pain (35). In one The division of patients and controls into two groups: with or without sexual dysfunctions based on FSFI with the cut-off of ≦26 points.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Sexual dysfunctions in psoriatic patients

Nowowiejska,

Karny,

Nesterowicz

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

IntroductionPsoriasis is one the most common skin diseases associated with a great decrease in the quality of patients’ lives.MethodsWe aimed to study sexual dysfunctions in psoriatic patients using the Female Sexual Function Index (FSFI) for women and the International Index of Erectile Function (IIEF) for men via an anonymous online survey. The study included 80 psoriatic patients and 75 controls without dermatoses.ResultsThere was a downward trend in the total IIEF score in psoriatic men compared to controls. 58% of male patients and 76% of controls had a normal IIEF score. There was no significant difference in IIEF between patients treated and not with systemic agents. 62% of female patients had a decreased FSFI score, whereas in the control group, the majority of subjects (54%) had a normal FSFI score. There was no significant difference in FSFI score between patients and controls. Female patients treated with systemic antipsoriatic agents had significantly worse lubrication, satisfaction with sexual life, and pain.DiscussionOur study has shown that the majority of questioned female psoriatic patients had sexual dysfunction according to FSFI, particularly they had worse satisfaction with sexual life and less sexual desire compared to women without psoriasis. The majority of male patients did not have sexual dysfunction according to IIEF, however, they had significantly worse overall satisfaction with sexual life and confidence to keep an erection. Systemic antipsoriatic treatment does not probably influence sexual dysfunctions in men but it does in women although we were not able to assess the severity or resolution of lesions after those treatments. However embarrassing, psoriatic patients should be questioned about their sexual lives by dermatologists, and more studies are needed to explore this matter.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Meeuwis and Türel Ermertcan et al obtained similar results to ours with decreased total FSFI in psoriatic women (29, 31). In a recent meta-analysis of sexual dysfunctions in psoriatic women, it has been found that female patients have bigger odds of dysfunctions (OR 2.67, 95% CI) and lower scores in all the domains of FSFI, except for pain (35). In one The division of patients and controls into two groups: with or without sexual dysfunctions based on FSFI with the cut-off of ≦26 points.…”

Section: Discussionmentioning

confidence: 99%

Sexual dysfunctions in psoriatic patients

Nowowiejska,

Karny,

Nesterowicz

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…A recent metanalysis of eight studies including 563 women with psoriasis and 525 controls identified significantly impaired sexual function in women with psoriasis compared to controls, suggesting that routine assessment of sexual health may be beneficial [ 31 ].…”

Section: Discussionmentioning

confidence: 99%

Prevalence of Female Sexual Dysfunction among Psoriatic Females: a Cross Sectional Case Controlled Study

Elsaie,

Hanafy,

Hussein

et al. 2023

Dermatol Pract Concept

View full text Add to dashboard Cite

Introduction: Sexual relationships are an integral part of females psychological and physiological wellbeing. Objectives: The study aimed to identify prevalence and impact of Female Sexual Dysfunction (FSD) in women affected with psoriasis. Methods: This cross-sectional study was carried out on 150 married females who were interviewed to answer Female Sexual Function Index (FSFI) questionnaire and were divided into two groups: the first group included 100 female patients complaining of psoriasis (50 suffering from moderate psoriasis and 50 with severe psoriasis). The disease severity was graded according to the Psoriasis Area and Severity Index (PASI) while the second group included 50 age matched women who served as controls. Results: Female sexual dysfunction (FSD) in psoriasis female groups was higher than that in the control group (47%, 24%, P < 0.05). The mean total scores of FSFI ranged from 12.30 to 34.20 and were significantly lower in the severe PASI affected group (22.34 ± 5.35) when compared to moderate PASI group (26.24 ± 2.67) or control group (28.79 ± 2.22). In addition, total scores were significantly lower among moderate PASI affected females when compared to control group. Conclusions: Sexual dysfunction should be routinely investigated in female patients with psoriasis in the case of moderate-severe disease due to its negative impact on quality of life. Further research over the effect of certain interventional programs on FSD should be considered for patients suffering from psoriasis.

show abstract

“…All the reviewed studies were identified as being of moderate to high quality and were eligible for inclusion in this review. The risk of bias was classified based on the proportion of ‘yes’ responses on the JBI criteria as follows: high <50%, moderate 50%–69% and low ≥70% 20,21 (Table 1).…”

Section: Methodsmentioning

confidence: 99%

Prevalence and associated factors of sexual dysfunction in premenopausal women with type 1 diabetes: A systematic review and meta‐analysis

et al. 2023

View full text Add to dashboard Cite

BackgroundSexual dysfunction (SD) in women with diabetes is a multifaceted complication driven by hormonal, neuropathic and psychosocial factors. It has been reported that the prevalence of SD is higher in women with type 1 diabetes compared to both women with type 2 diabetes and women without diabetes. However, prevalence estimates of SD in women with type 1 diabetes are variable, due to the heterogeneity of the conducted studies and the various confounding factors that are associated with SD.AimThis review aimed to estimate the prevalence of SD in premenopausal women with type 1 diabetes compared to women without diabetes; consider current methods for measuring SD; and identify factors associated with SD in women with type 1 diabetes.MethodA systematic review of the literature was conducted. Four electronic databases (Embase, MEDLINE, CINAHL, PsycINFO) were searched between 15 March and 29 April 2022, the search was updated on 4 February 2023 to identify studies that assessed SD in women with type 1 diabetes.FindingsThe search yielded in 1104 articles; of these, 180 were assessed for eligibility. A meta‐analysis of eight eligible studies revealed that the odds of experiencing SD is three times higher in women with type 1 diabetes compared to women without diabetes (OR = 3.8 95%CI 1.8–8.0, p < 0.001). The most commonly used measure of SD was the female sexual function index (FSFI); in three studies, this was combined with the female sexual distress scale (FSDS). Factors that have shown significant association with SD are depression, anxiety and duration of diabetes.ConclusionThis review has shown that SD is a significant issue for women with type 1 diabetes. These findings should encourage diabetes professionals and policymakers to give more attention to female SD (FSD) by incorporating it into care pathways and clinical guidelines.

show abstract

Female sexual dysfunction in psoriasis: a systematic review and meta-analysis using the Female Sexual Function Index

Cited by 5 publications

References 39 publications

Sexual dysfunctions in psoriatic patients

Sexual dysfunctions in psoriatic patients

Prevalence of Female Sexual Dysfunction among Psoriatic Females: a Cross Sectional Case Controlled Study

Prevalence and associated factors of sexual dysfunction in premenopausal women with type 1 diabetes: A systematic review and meta‐analysis

Contact Info

Product

Resources

About